glp-1 and gip/glp-1 receptor agonists Targeting GLP-1, GIP & GCG in Obesity Type 2 Diabetes Research Dual and Triple Gut Peptide

Methods A single-centre retrospective observational study

This formula is convenient to use with just one capsule per serving

Methods A comprehensive literature search was conducted to synthesize the current preclinical and clinical evidence

A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year

This paper reviews the physiological, pharmacologic, and clinical foundations linking GLP-1 RA therapy to reproductive outcomes

Glucose-dependent insulinotropic polypeptide (GIP) is secreted by enteroendocrine K cells, primarily located in the upper small intestine, in response to food intake and plays a significant role in the postprandial regulation of nutrient metabolism